Archive

Approximately 1.2 billion will be available for the lower-income economies participating in the COVAX Advance Market Commitment (AMC).

Confirmatory tests carried out by the Institute Pasteur in Paris detected Neisseria meningitidis – one of the most frequent types of bacterial meningitis with the potential to cause large epidemics.